Cervical cancer represents a significant portion of the global cancer burden for women, with
low-and middle-income countries carrying the bulk of this burden. Additionally, underserved …

Background Cisplatin-based concurrent chemoradiation is the standard treatment for locally
advanced cervical cancer. In view of the difficulties associated with implementation of …

The establishment of link between high-risk human papillomavirus (HPV) infection and
occurrence of cervical cancer has resulted in development of various HPV related control …

Cervical cancer is one of the most common cancers in developing nations. It has had a
tremendous impact on the lifetime of millions of women over the last century and continues …

Low-and middle-income countries (LMICs) have a large burden of cancer with differential
population needs and outcomes compared to high-income countries. Access to …

Background Survival outcomes for cervical cancer differ between countries and world
regions. Locally advanced cervical cancer (LACC) is associated with poorer outcomes than …

Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause
of cancer death in women. The discrepancy in cervical cancer incidence and mortality …

Methods The number of cervical cancer cases was estimated for each state and union
territory using the nearest population-based cancer registry and verified against published …

Abstract Background & Purpose To report disease-free survival (DFS) for volume-based and
point-A based brachytherapy (BT) in locally advanced cervical cancer. Materials & Methods …

Low-and middle-income countries (LMICs) 1 have witnessed a rise in mortality due to
noncommunicable diseases in the last 2 decades. 2 Although cancer accounted for 9.3 …